Every SEC Form 3/4/5 on record for this filer (CIK 1681782) — 3 issuers, 62 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| KLRS | Kalaris Therapeutics, Inc. | Chief Accounting Officer | 2025-03-27 → 2026-03-23 | 3 | −$21,005 |
| ALVR | Allovir, Inc. | Chief Accounting Officer | 2020-07-30 → 2025-02-24 | 45 | −$707,262 |
| PTI | PROTEOSTASIS THERAPEUTICS, INC. | See Remarks · lapsed | 2016-08-08 → 2017-04-05 | 3 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| KLRS | 2026-03-20 | Sell | 1,915 | $6.72 | $12,869 | — |
| KLRS | 2025-03-26 | Sell | 907 | $8.97 | $8,136 | 1,925 |
| ALVR | 2025-02-21 | Sell | 96 | $10.08 | $968 | 2,832 |
| ALVR | 2025-01-23 | Sell | 32 | $9.45 | $302 | 2,932 |
| ALVR | 2025-01-23 | Sell | 4 | $9.94 | $40 | 2,928 |
| ALVR | 2025-01-10 | Sell | 332 | $0.44 | $146 | 68,174 |
| ALVR | 2024-11-19 | Sell | 554 | $0.55 | $305 | 68,506 |
| ALVR | 2024-11-05 | Sell | 1,655 | $0.86 | $1,423 | 69,060 |
| ALVR | 2024-10-22 | Sell | 486 | $0.77 | $374 | 70,715 |
| ALVR | 2024-10-21 | Sell | 479 | $0.78 | $374 | 71,201 |
1 of 3 issuers are covered and open a security page; the rest are on file here only.
